As US DNA advisory body redefines itself.
Explore the source record for details and available documents.
Advisory Committees↗
SEARCH · PubMed Health
Results for “Recombinant DNA Advisory Committee”
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Genetic experiment by military approved.
Explore the source record for details and available documents.
Advisory Committees↗
Special informed consent requirements are included in protocol review procedures.
Explore the source record for details and available documents.
Advisory Committees↗
Regulatory structure for biotechnology proposed.
Explore the source record for details and available documents.
Advisory Committees↗
The social warp of science: writing the history of genetic engineering policy.
Explore the source record for details and available documents.
Advisory Committees↗
NIH may loosen recombinant DNA research guidelines.
Explore the source record for details and available documents.
Advisory Committees↗
Minutes of meeting: March 11-12, 1999: Working Group III Report: ethical, legal, and societal issues.
Explore the source record for details and available documents.
Advisory Committees↗
Watch on human experiments.
Explore the source record for details and available documents.
Advisory Committees↗
Procedures to be followed for expedited review of single patient protocols -- recommendations of the RAC, March 2, 1993.
Explore the source record for details and available documents.
Advisory Committees↗
Recombinant DNA research: the scope and limits of regulation.
The paper provides an overview of public policy issues pertaining to the use of gene-splicing (recombinant DNA [deoxyribonucleic acid]) techniques in research and for industrial applications. Included is a discussion of the regulatory framework at the federal and institutional levels. The principal limitation of the current federal guidelines is its failure to provide mandatory coverage for private sector activities. Four municipalities and two states have passed their own legislation to remedy the situation. These enactments and their tie-in to the public health sector are examined.
Advisory Committees↗
DNA guidelines. More relaxation.
Explore the source record for details and available documents.
Advisory Committees↗
Minutes of meeting: September 24-25, 1998.
Explore the source record for details and available documents.
Advisory Committees↗
New DNA committee further eases research controls.
Explore the source record for details and available documents.
Advisory Committees↗
DNA guidelines for further attenuation.
Explore the source record for details and available documents.
Advisory Committees↗
Despite doubts RAC moving to widen role.
Explore the source record for details and available documents.
Advisory Committees↗
Industry gene-splice field tests approved.
Explore the source record for details and available documents.
Advisory Committees↗
Should dying patients receive untested genetic methods?
Explore the source record for details and available documents.
Advisory Committees↗
Regulation of genetic engineering: less concern about Frankensteins but time for action on commercial production.
Explore the source record for details and available documents.
Advisory Committees↗